Cargando…

IL‐22‐mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury

Kidney damage initiates the deteriorating metabolic states in tubule cells that lead to the development of end‐stage renal disease (ESTD). Interleukin‐22 (IL‐22) is an effective therapeutic antidote for kidney injury via promoting kidney recovery, but little is known about the underlying molecular m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wei, Shen, Yilan, Fan, Jiajun, Zeng, Xian, Zhang, Xuyao, Luan, Jingyun, Wang, Yichen, Zhang, Jinghui, Fang, Si, Mei, Xiaobin, Zhao, Zhen, Ju, Dianwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901723/ https://www.ncbi.nlm.nih.gov/pubmed/33634980 http://dx.doi.org/10.1002/ctm2.324

Ejemplares similares

Interleukin-22 drives a metabolic adaptive reprogramming to maintain mitochondrial fitness and treat liver injury
por: Chen, Wei, et al.
Publicado: (2020)

Interleukin-22 Attenuated Renal Tubular Injury in Aristolochic Acid Nephropathy via Suppressing Activation of NLRP3 Inflammasome
por: Wang, Shaofei, et al.
Publicado: (2019)

Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation
por: Wang, Shaofei, et al.
Publicado: (2017)

Tethering Interleukin-22 to Apolipoprotein A-I Ameliorates Mice from Acetaminophen-induced Liver Injury
por: Chen, Wei, et al.
Publicado: (2017)

Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment
por: Zhang, Jinghui, et al.
Publicado: (2021)

NOD-Like Receptor Protein 3 Inflammasome-Dependent IL-1β Accelerated ConA-Induced Hepatitis
por: Luan, Jingyun, et al.
Publicado: (2018)

Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer
por: Zhang, Xuyao, et al.
Publicado: (2019)

Interleukin-22 in Renal Protection and Its Pathological Role in Kidney Diseases
por: Ma, Qianqian, et al.
Publicado: (2022)

Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin E
por: Wang, Yichen, et al.
Publicado: (2018)

Regulating autophagy facilitated therapeutic efficacy of the sonic Hedgehog pathway inhibition on lung adenocarcinoma through GLI2 suppression and ROS production
por: Fan, Jiajun, et al.
Publicado: (2019)

A Novel Bifunctional Fusion Protein, Vunakizumab-IL22, for Protection Against Pulmonary Immune Injury Caused by Influenza Virus
por: Han, Lei, et al.
Publicado: (2021)

A novel and promising therapeutic approach for NSCLC: recombinant human arginase alone or combined with autophagy inhibitor
por: Shen, Weitao, et al.
Publicado: (2017)

Insights into CD47/SIRPα axis-targeting tumor immunotherapy
por: Zhang, Xuyao, et al.
Publicado: (2018)

Targeting the autophagy promoted antitumor effect of T-DM1 on HER2-positive gastric cancer
por: Zhang, Jinghui, et al.
Publicado: (2021)

Correction: Targeting the autophagy promoted antitumor effect of T-DM1 on HER2-positive gastric cancer
por: Zhang, Jinghui, et al.
Publicado: (2023)

Targeting 4-1BB and PD-L1 induces potent and durable antitumor immunity in B-cell lymphoma
por: Wang, Yichen, et al.
Publicado: (2022)

VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses
por: Shen, Yilan, et al.
Publicado: (2021)

The role of autophagy in asparaginase-induced immune suppression of macrophages
por: Song, Ping, et al.
Publicado: (2017)

Simultaneous blockade of VEGF-B and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response
por: Cao, Zhonglian, et al.
Publicado: (2023)

Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming
por: Liu, Jia, et al.
Publicado: (2020)

Inflammasome: A Double-Edged Sword in Liver Diseases
por: Luan, Jingyun, et al.
Publicado: (2018)

Autophagy suppression potentiates the anti-glioblastoma effect of asparaginase in vitro and in vivo
por: Chen, Qicheng, et al.
Publicado: (2017)

Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer
por: Xu, Caili, et al.
Publicado: (2022)

Cell Membrane-Derived Vesicle: A Novel Vehicle for Cancer Immunotherapy
por: Xu, Caili, et al.
Publicado: (2022)

Editorial: Combinational immunotherapy of cancer: novel targets, mechanisms, and strategies
por: Nan, Yanyang, et al.
Publicado: (2023)

Editorial: Community series in combinational immunotherapy of cancer: novel targets, mechanisms, and strategies, volume II
por: Xu, Caili, et al.
Publicado: (2023)

Roles of PFKFB3 in cancer
por: Shi, Linlin, et al.
Publicado: (2017)

931. Host PFKFB3-dependent glycolytic reprogramming as a broad-spectrum antiviral strategy
por: Yuan, Shuofeng, et al.
Publicado: (2023)

Overexpression of PFKFB3 promotes cell glycolysis and proliferation in renal cell carcinoma
por: Li, Jun, et al.
Publicado: (2022)

Therapeutic Opportunities of IL-22 in Non-Alcoholic Fatty Liver Disease: From Molecular Mechanisms to Clinical Applications
por: Zai, Wenjing, et al.
Publicado: (2021)

PFKFB3-mediated glycometabolism reprogramming modulates endothelial differentiation and angiogenic capacity of placenta-derived mesenchymal stem cells
por: Zhang, Yang, et al.
Publicado: (2022)

Myeloid PFKFB3-mediated glycolysis promotes kidney fibrosis
por: Yang, Qiuhua, et al.
Publicado: (2023)

Mutation of regulatory phosphorylation sites in PFKFB2 worsens renal fibrosis
por: Lee, Mardiana, et al.
Publicado: (2020)

Reprogramming of glucose metabolism via PFKFB4 is critical in FGF16-driven invasion of breast cancer cells
por: Kar, Swarnali, et al.
Publicado: (2023)

Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions
por: Okabe, Seiichi, et al.
Publicado: (2022)

The role of interleukin-22 in lung health and its therapeutic potential for COVID-19
por: Fang, Si, et al.
Publicado: (2022)

PFKFB3-Mediated Glycolysis Boosts Fibroblast Activation and Subsequent Kidney Fibrosis
por: Yang, Qiuhua, et al.
Publicado: (2023)

The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue
por: Li, Ximing, et al.
Publicado: (2020)

Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease Development/Progression, and Potential as Therapeutic Targets
por: Kotowski, Krzysztof, et al.
Publicado: (2021)

GSDMD contributes to myocardial reperfusion injury by regulating pyroptosis
por: Ye, Xiaomiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qi0qk1aeobk61kgsdniv5cu0mg